“…Supplementation trials have been carried out to test the epidemiological association between AA and plasma lipids. The results of some trials re¯ected the epidemiological observations (Samuel & Shalchi, 1964;Spittle, 1971;Gatto et al, 1996;Fidanza et al, 1982;Ginter, 1979) while others showed no effect despite a wide range in the amounts (0.2± 6 g/d) of the supplements which were consumed (Samuel & Shalchi, 1964;Spittle, 1971;Buzzard et al, 1982;Aro et al, 1988;Burr et al, 1985;Crawford et al, 1975;Wahlberg & Walldius, 1982;Khan & Seedarnee, 1981;Johnson & Obenshain, 1981;Menne et al, 1975;Peterson et al, 1995). However, the quality of the trials has been variable (Hemila, 1992) and some trials have suffered from the lack of a control group, poor dietary control, no evidence of compliance, a heterogeneous population with respect to pathological conditions and AA status, and the use of elderly subjects who have a recognised age-related alteration in the metabolism of AA.…”